Industry
Pharmaceuticals
Developers of branded and generic drugs. Value creation rests on R&D pipelines, patent lifecycles, regulatory approvals and pricing power versus payers.
Total Companies
1.352
1.301 stocks
| Empresa | Último precio | Cambio de precio | Capitalización bursátil | ||
|---|---|---|---|---|---|
|
|
|
Eli Lilly and Co
LLY
|
$1.143,5 |
-5,5%
|
$1,08 T |
|
|
|
Johnson & Johnson
JNJ
|
$257,4 |
-3,1%
|
$619,62 B |
|
|
|
Roche Holding AG
ROG
|
CHf324,9 |
+4,1%
|
$326,70 B |
|
|
|
Merck & Co Inc
MRK
|
$130,92 |
+0,4%
|
$323,35 B |
|
|
|
Novartis AG
NOVN
|
CHf126,38 |
-0,3%
|
$299,63 B |
|
|
|
AstraZeneca PLC
AZN
|
12.632 |
-3,8%
|
$263,84 B |
|
|
|
Novo Nordisk A/S
NOVO B
|
kr306,85 |
-7,3%
|
$209,30 B |
|
|
|
Pfizer Inc
PFE
|
$25,071 |
-0,3%
|
$142,89 B |
|
|
|
Nuvo Pharmaceuticals Inc
MRV
|
CA$29,81 |
+5,1%
|
$155,57 B |
1.296 resultados ocultos
Crea una cuenta gratuita para desbloquear acceso adicional y mejora para ver todos los resultados
Crear cuenta gratuita
